Camille Aupiais

Paris, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 45 publications

SARS-CoV-2 Reinfection and Risk of Multisystem Inflammatory Syndrome in Children: A Case-Control Study.

SARS-CoV-2 Reinfection and Risk of Multisystem Inflammatory Syndrome in Children: A Case-Control Study.

Journal: The Pediatric infectious disease journal

Published: May 20, 2026

Shifts in unidentified-pathogen acute hematogenous osteomyelitis incidence after non-pharmaceutical interventions highlight the role of seasonal viruses: an interrupted time-series analysis.

Shifts in unidentified-pathogen acute hematogenous osteomyelitis incidence after non-pharmaceutical interventions highlight the role of seasonal viruses: an interrupted time-series analysis.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: April 28, 2026

A contemporary overview of severe community-acquired bacterial infections in pediatric intensive care units.

A contemporary overview of severe community-acquired bacterial infections in pediatric intensive care units.

Journal: Annals of intensive care

Published: March 25, 2026

Respiratory evolution after antenatal betamethasone dose reduction in very preterm neonates: a post hoc analysis of the BETADOSE trial.

Respiratory evolution after antenatal betamethasone dose reduction in very preterm neonates: a post hoc analysis of the BETADOSE trial.

Journal: European journal of pediatrics

Published: March 11, 2026

Association between nirsevimab coverage and pediatric emergency department visits for bronchiolitis in 12 European countries: An interrupted time-series analysis.

Association between nirsevimab coverage and pediatric emergency department visits for bronchiolitis in 12 European countries: An interrupted time-series analysis.

Journal: PLoS medicine

Published: February 24, 2026

Nirsevimab Treatment of RSV Bronchiolitis in Pediatric Emergency Departments.

Nirsevimab Treatment of RSV Bronchiolitis in Pediatric Emergency Departments.

Journal: JAMA network open

Published: October 30, 2025

Effectiveness of nirsevimab against hospitalisation for RSV-bronchiolitis during high RSV-B circulation in the second year of nationwide implementation in France: a test-negative case-control study.

Effectiveness of nirsevimab against hospitalisation for RSV-bronchiolitis during high RSV-B circulation in the second year of nationwide implementation in France: a test-negative case-control study.

Journal: The Lancet regional health. Europe

Published: May 15, 2025

Nasopharyngeal Carriage and Antibiotic Resistance in Children With Sickle Cell Disease: The DREPANOBACT French Multicenter Prospective Study.

Nasopharyngeal Carriage and Antibiotic Resistance in Children With Sickle Cell Disease: The DREPANOBACT French Multicenter Prospective Study.

Journal: The Pediatric infectious disease journal

Published: April 15, 2025

Association between socioeconomic status and nonurgent presentations to pediatric emergency departments: a retrospective study.

Association between socioeconomic status and nonurgent presentations to pediatric emergency departments: a retrospective study.

Journal: European journal of emergency medicine : official journal of the European Society for Emergency Medicine

Published: January 24, 2025

Pediatric Hospitalizations and Emergency Department Visits Related to Mental Health Conditions and Self-Harm.

Pediatric Hospitalizations and Emergency Department Visits Related to Mental Health Conditions and Self-Harm.

Journal: JAMA network open

Published: October 29, 2024

Nirsevimab effectiveness on paediatric emergency visits for RSV bronchiolitis: a test-negative design study.

Nirsevimab effectiveness on paediatric emergency visits for RSV bronchiolitis: a test-negative design study.

Journal: European journal of pediatrics

Published: October 16, 2024

Did the resurgence of childhood lower respiratory infections offset the initial benefit of COVID-19-related non-pharmaceutical interventions in children? A time-series analysis.

Did the resurgence of childhood lower respiratory infections offset the initial benefit of COVID-19-related non-pharmaceutical interventions in children? A time-series analysis.

Journal: BMC medicine

Published: August 09, 2024

Showing 1-12 of 45

Last Updated: 09/26/2026